Cost-effectiveness analysis of monthly, 3-monthly, and 6-monthly long-acting injectable and oral paliperidone in adults with schizophrenia.

Wang, Grace Hsin-Min; Svensson, Mikael; Shao, Hui; Vouri, Scott Martin; Park, Haesuk

Wang, Grace Hsin-Min; Svensson, Mikael; Shao, Hui; Vouri, Scott Martin; Park, Haesuk.

Afiliação

Wang GH; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville.
Svensson M; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville.
Shao H; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville.
Vouri SM; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville.
Park H; Center for Drug Evaluation and Safety, College of Pharmacy, University of Florida, Gainesville.

J Manag Care Spec Pharm ; 29(8): 884-895, 2023 Aug.

Article em En | MEDLINE | ID: mdl-37523313

Assuntos

Antipsicóticos; Esquizofrenia; Humanos; Adulto; Palmitato de Paliperidona; Esquizofrenia/tratamento farmacológico; Análise de Custo-Efetividade; Qualidade de Vida; Antipsicóticos/uso terapêutico; Recidiva; Preparações de Ação Retardada

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos Tipo de estudo: Clinical_trials / Health_economic_evaluation / Observational_studies / Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google